PASSAGE BIO INC. - COMMON STOCK

Passage Bio Announces Interim Data from upliFT-D Study in FTD-GRN and Provides Business Updates

10 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

13 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference

06 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference

24 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference

23 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024)

16 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Welcomes Tom Kassberg to Board of Directors

10 Sep 2024 07:52:00 By Nasdaq GlobeNewswire

Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference

30 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

08 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio to Participate in Upcoming Investor Conferences

06 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration

01 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients

16 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference

05 Jun 2024 07:30:00 By Nasdaq GlobeNewswire

Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award

21 May 2024 08:00:00 By Nasdaq GlobeNewswire

Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

14 May 2024 07:00:01 By Nasdaq GlobeNewswire

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

22 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program

05 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights

04 Mar 2024 07:00:17 By Nasdaq GlobeNewswire

Passage Bio to Participate in Upcoming Investor Conferences

27 Feb 2024 07:00:26 By Nasdaq GlobeNewswire

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

31 Jan 2024 07:30:00 By Nasdaq GlobeNewswire